Stocks · Health care · Pharmaceutical Preparations

Korro Bio, Inc.

KRRO Clue Score32

United States Fiscal year ends December CIK 0001703647 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

18 insiders · 4 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Lynx1 Capital Management LP entity

10% owner

$884.75K (4)

—

+$884.75K

3,169,769

21.53%

$37.23M

+2.8%

Scott D Sandell

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Edward T Mathers

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Ali Behbahani

Director

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Forest Baskett

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Carmen Chang

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Anthony A. Florence Jr.

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Mohamad Makhzoumi

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Paul Edward Walker

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Rick Yang

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

New Enterprise Associates 17, L.P. entity

10% owner

—

—

—

1,297,893

8.81%

$15.24M

+19.0%

Jean Francois Formela

Director

—

—

—

273,703

1.86%

$3.21M

−57.1%

Ram Aiyar

President and CEO

—

—

—

69,046

0.4689%

$810.97K

—

Jeffrey Cerio

General Counsel

—

—

—

41,793

0.2838%

$490.88K

—

Loic A Vincent

Chief Scientific Officer

—

—

—

25,797

0.1752%

$303.00K

—

Todd Chappell

Chief Operating Officer

—

—

—

24,464

0.1661%

$287.34K

—

Oliver Dolan

Senior Vice President, Finance

—

—

—

16,241

0.1103%

$190.76K

—

Vineet Agarwal

Chief Financial Officer

—

—

—

0

0.0000%

$0.00

—